BY OUR PLATFORMS
BY THERAPEUTIC AREA
BY RESEARCH STAGE
We are a leading CRISPR licensed Contract Research Organization that uses zebrafish to carry out a number of experimental services focused on analyzing the safety, efficacy and biomedical relevance of new compounds.
The experimental approach that we carry out with zebrafish larvae fulfills the purpose of reducing, refining and replacing the use of experimental animal models and fully aligns us with the policies proposed by the EU Reference Laboratory for alternatives to animal testing (EURL-ECVAM ).
Reduce: thanks to our innovative approach, we can introduce zebrafish larvae into the drug discovery pipeline, gaining more knowledge about a molecule and reducing subsequent use by mammals in regulatory phases.
Refine: the fact that the zebrafish larva is transparent and we can see all the organs working through the skin allows us to refine techniques that with traditional models are always very invasive. The zebrafish is an open window to biomedicine.
Replace: if we can use a robust and predictive alternative model in the drug discovery pipeline, we will succeed in replacing the use of mammals.